USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 13, 2013 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| May 13, 2013 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 9, 2012 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 14, 2012 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 14, 2012 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 25, 2012 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 7, 2012 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jun 29, 2012 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 7, 2012 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 7, 2012 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 31, 2012 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 19, 2012 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| May 18, 2012 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 18, 2012 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| May 18, 2012 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| May 16, 2012 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| May 16, 2012 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Sep 23, 2011 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Sep 23, 2011 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Sep 23, 2011 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Sep 17, 2011 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 7, 2011 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 6, 2011 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in orthopedic bone, ligament, tendon and cartilage regeneration; pharmaceutical preparations, namely, biologics for use in orthopedic bone, ligament, tendon and cartilage regeneration; pharmaceutical preparations comprising DNA or protein for use in orthopedic bone, ligament, tendon and cartilage regeneration; pharmaceutical hydrogels comprising a biologic for use in orthopedic bone, ligament, tendon and cartilage regeneration; nutraceuticals for use in orthopedic bone, ligament, tendon and cartilage regeneration
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005